You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for New Drug Application (NDA): 019854


✉ Email this page to a colleague

« Back to Dashboard


NDA 019854 describes DEPEN, which is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. Additional details are available on the DEPEN profile page.

The generic ingredient in DEPEN is penicillamine. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the penicillamine profile page.
Summary for 019854
Tradename:DEPEN
Applicant:Mylan Speciality Lp
Ingredient:penicillamine
Patents:0
Pharmacology for NDA: 019854
Medical Subject Heading (MeSH) Categories for 019854
Suppliers and Packaging for NDA: 019854
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEPEN penicillamine TABLET;ORAL 019854 NDA Meda Pharmaceuticals Inc. 0037-4401 0037-4401-01 100 TABLET in 1 BOTTLE (0037-4401-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.